Doximity (NYSE:DOCS) Downgraded by Barclays to Hold

Barclays lowered shares of Doximity (NYSE:DOCS) from a strong-buy rating to a hold rating in a research note published on Thursday morning,Zacks.com reports.

DOCS has been the subject of a number of other research reports. Loop Capital set a $31.00 target price on Doximity in a research note on Tuesday, March 17th. KeyCorp lowered Doximity from an “overweight” rating to a “sector weight” rating in a research note on Thursday. Piper Sandler boosted their target price on Doximity from $40.00 to $42.00 and gave the company an “overweight” rating in a research note on Friday, February 20th. Leerink Partners lowered their target price on Doximity from $31.00 to $25.00 and set an “outperform” rating for the company in a research note on Thursday. Finally, Zacks Research raised Doximity from a “strong sell” rating to a “hold” rating in a research note on Tuesday, April 21st. Two investment analysts have rated the stock with a Strong Buy rating, seven have given a Buy rating and fourteen have given a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $30.62.

Doximity Stock Performance

NYSE DOCS opened at $18.93 on Thursday. Doximity has a 1-year low of $17.15 and a 1-year high of $76.51. The firm has a 50-day moving average of $23.94. The company has a market cap of $3.50 billion, a price-to-earnings ratio of 19.12, a PEG ratio of 1.28 and a beta of 1.36.

Doximity announced that its board has authorized a share buyback program on Thursday, February 5th that permits the company to buyback $500.00 million in shares. This buyback authorization permits the company to purchase up to 8% of its stock through open market purchases. Stock buyback programs are typically an indication that the company’s management believes its stock is undervalued.

Insider Transactions at Doximity

In other news, Director Kira Scherer Wampler sold 9,000 shares of the stock in a transaction dated Thursday, May 7th. The shares were sold at an average price of $26.06, for a total transaction of $234,540.00. Following the completion of the sale, the director directly owned 19,839 shares in the company, valued at approximately $517,004.34. This represents a 31.21% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Siddharth Sitaram sold 2,309 shares of the stock in a transaction dated Monday, May 11th. The stock was sold at an average price of $25.77, for a total transaction of $59,502.93. Following the sale, the insider owned 89,396 shares of the company’s stock, valued at approximately $2,303,734.92. This represents a 2.52% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last quarter, insiders have sold 18,055 shares of company stock valued at $456,061. 31.30% of the stock is currently owned by company insiders.

Institutional Trading of Doximity

Institutional investors have recently modified their holdings of the company. Root Financial Partners LLC purchased a new stake in shares of Doximity during the third quarter worth about $30,000. Whittier Trust Co. of Nevada Inc. boosted its holdings in shares of Doximity by 59.5% during the third quarter. Whittier Trust Co. of Nevada Inc. now owns 480 shares of the company’s stock worth $35,000 after purchasing an additional 179 shares during the period. Northwestern Mutual Wealth Management Co. boosted its holdings in shares of Doximity by 99.5% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 796 shares of the company’s stock worth $35,000 after purchasing an additional 397 shares during the period. Toth Financial Advisory Corp lifted its holdings in Doximity by 100.0% in the fourth quarter. Toth Financial Advisory Corp now owns 1,000 shares of the company’s stock worth $44,000 after buying an additional 500 shares during the period. Finally, Atlantic Union Bankshares Corp lifted its holdings in Doximity by 136.9% in the third quarter. Atlantic Union Bankshares Corp now owns 616 shares of the company’s stock worth $45,000 after buying an additional 356 shares during the period. 87.19% of the stock is currently owned by hedge funds and other institutional investors.

Doximity News Roundup

Here are the key news stories impacting Doximity this week:

• Positive Sentiment: Doximity said revenue still grew year over year, and its earnings call highlighted strong engagement from AI tool adoption, suggesting the platform is gaining traction with physicians. Doximity Stock Falls on Q4 Earnings Miss, Revenues Beat, Margins Down
• Positive Sentiment: Doximity announced a partnership with Aledade to bring clinical AI tools into value-based care workflows, which could support longer-term adoption and monetization. DOCS Teams Up With Aledade to Bring Clinical AI to Value-Based Care
• Neutral Sentiment: Several articles noted the stock has become technically oversold after a sharp selloff, which could set up a bounce if sentiment improves. Down 25.7% in 4 Weeks, Here’s Why Doximity (DOCS) Looks Ripe for a Turnaround
• Negative Sentiment: Doximity missed quarterly earnings estimates and issued fiscal 2027 revenue guidance below Wall Street expectations, raising concerns that growth is slowing. Doximity, Inc. (DOCS) Q4 2026 Earnings Call Transcript
• Negative Sentiment: Analysts turned more cautious, with multiple firms cutting price targets or downgrading the stock, including Baird, Wells Fargo, BTIG, JPMorgan, Mizuho, BMO, Needham and Truist. DOCS vs. HIMS: Which Stock Is the Better Value Option?
• Negative Sentiment: Investor caution also increased after insider selling was disclosed, even though it was tied to a pre-arranged 10b5-1 plan and tax withholding. Doximity (NYSE:DOCS) Insider Siddharth Sitaram Sells 2,309 Shares

Doximity Company Profile

Doximity, trading as DOCS, operates a digital professional network and communications platform designed primarily for clinicians. Headquartered in San Francisco, the company connects physicians, nurse practitioners, physician assistants and other healthcare professionals, providing tools that streamline clinical communication, telehealth delivery and access to specialty-specific medical information. Its platform is positioned as a professional hub where clinicians manage their workflows, stay current with medical news and collaborate securely with peers.

The company’s offerings include secure messaging and video telehealth capabilities that enable clinicians to consult with patients and colleagues while protecting patient information.